secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-02-05T23:59:59+00:00
Accession:  0000950170-24-011013
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharmaceuticals updates investor presentation; no material changes disclosed
--------------------------------------------------------------------------------

- Filed updated corporate presentation dated February 2, 2024, as Exhibit 99.1.
- Presentation title slide only provided; no specific operational or financial updates included.
- No new drug pipeline milestones, financial results, or strategic changes announced.
- Routine disclosure under Regulation FD; presentation available on company website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/0000950170-24-011013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024011013/crbp-20240205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-011013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer